{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:49:56Z","timestamp":1791348596168,"version":"4.3.1"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.prp.2026.156705","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:47:16Z","timestamp":1790783236000},"page":"156705","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Systematic review of gallbladder disorders: Molecular pathogenesis, biomarkers, diagnostic approaches, and emerging therapeutic strategies"],"prefix":"10.1016","volume":"288","author":[{"given":"Gunasekar","family":"Ramanan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saroj","family":"Kumari S","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeeva","family":"Umasankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yokesh","family":"Shanmugam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6869-3446","authenticated-orcid":false,"given":"Lokeshvar","family":"Ravikumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.prp.2026.156705_bib1","doi-asserted-by":"crossref","first-page":"5580","DOI":"10.3390\/cancers14225580","article-title":"Gallbladder cancer: current multimodality treatment concepts and future directions","volume":"14","author":"Sturm","year":"2022","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.prp.2026.156705_bib2","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.3390\/biomedicines13061372","article-title":"Molecular mechanisms of lymph node metastasis in gallbladder cancer: insights into the tumor microenvironment","volume":"13","author":"Tang","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.prp.2026.156705_bib3","article-title":"HER2-targeted therapy combined with multidisciplinary management in advanced gallbladder cancer: a case report with 90-month survival","volume":"15","author":"Wang","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.prp.2026.156705_bib4","unstructured":"Gupta A., Satish A., Singh K., Saxena P. Gallbladder Carcinoma: A Comprehensive Review and Recent Updates."},{"key":"10.1016\/j.prp.2026.156705_bib5","doi-asserted-by":"crossref","DOI":"10.1177\/10732748261433619","article-title":"Integrative molecular insights into epidemiological, genetic, and metabolic risk factors of gallbladder cancer: implications for biomarkers, therapeutic targeting, and future perspectives","volume":"33","author":"Jaiswar","year":"2026","journal-title":"Cancer Control."},{"issue":"52","key":"10.1016\/j.prp.2026.156705_bib6","doi-asserted-by":"crossref","first-page":"38952","DOI":"10.1039\/D4RA07114J","article-title":"Advancements in nanotechnology-driven photodynamic and photothermal therapies: mechanistic insights and synergistic approaches for cancer treatment","volume":"14","author":"Shabnum","year":"2024","journal-title":"RSC Adv."},{"key":"10.1016\/j.prp.2026.156705_bib7","doi-asserted-by":"crossref","DOI":"10.1186\/s41065-025-00608-z","article-title":"Review of risk factors and surgical treatment progress for gallbladder cancer","author":"Feng","year":"2025","journal-title":"Hereditas"},{"issue":"4","key":"10.1016\/j.prp.2026.156705_bib8","first-page":"1760","article-title":"Acute Cholelithiasis with Calculous Cholecystitis and Impending Perforation: A Rare Presentation of Salmonella Typhi","volume":"19","author":"Kumar","year":"2025","journal-title":"Asian J Pharm."},{"issue":"7","key":"10.1016\/j.prp.2026.156705_bib9","doi-asserted-by":"crossref","DOI":"10.5306\/wjco.v16.i7.107781","article-title":"Early detection of gallbladder cancer: current status and future perspectives","volume":"16","author":"Sarangi","year":"2025","journal-title":"World J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2026.156705_bib10","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41572-022-00398-y","article-title":"Gallbladder cancer","volume":"8","author":"Roa","year":"2022","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.prp.2026.156705_bib11","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.humpath.2022.06.013","article-title":"Gallbladder carcinomas: review and updates on morphology, immunohistochemistry, and staging","volume":"132","author":"Lee","year":"2023","journal-title":"Human. Pathol."},{"key":"10.1016\/j.prp.2026.156705_bib12","article-title":"Gallbladder cancer: current and future treatment options","volume":"14","author":"Zhou","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.prp.2026.156705_bib13","article-title":"The genetic and epidemiological dimensions of gallbladder cancer: toward effective therapeutic strategies","author":"Siddiqui","year":"2025","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.prp.2026.156705_bib14","unstructured":"Board P.A. Gallbladder Cancer Treatment (PDQ\u00ae). InPDQ Cancer Information Summaries [Internet] 2025. National Cancer Institute (US)."},{"key":"10.1016\/j.prp.2026.156705_bib15","doi-asserted-by":"crossref","DOI":"10.1186\/s12935-026-04349-5","article-title":"Molecular convergence in gallbladder cancer: MEK\u2013ERK signalling at the crossroads of oncogenic hubs and pathway cross-talks","author":"Jaiswar","year":"2026","journal-title":"Cancer Cell. Int."},{"key":"10.1016\/j.prp.2026.156705_bib16","article-title":"Molecular pathogenesis of gallbladder carcinoma: Current perspectives","author":"Goel","year":"2023","journal-title":"J. Gastrointest. Oncol."},{"issue":"3","key":"10.1016\/j.prp.2026.156705_bib17","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ccell.2025.02.011","article-title":"Multimodal integration of liquid biopsy and radiology for the noninvasive diagnosis of gallbladder cancer and benign disorders","volume":"43","author":"Yang","year":"2025","journal-title":"Cancer Cell."},{"issue":"9","key":"10.1016\/j.prp.2026.156705_bib18","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1158\/1078-0432.CCR-25-2153","article-title":"HER2 positivity as a prognostic biomarker and therapeutic target in advanced biliary tract cancer: a multi-institutional analysis","volume":"32","author":"Lee","year":"2026","journal-title":"Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.prp.2026.156705_bib19","doi-asserted-by":"crossref","first-page":"676","DOI":"10.4103\/ijpm.ijpm_649_25","article-title":"Tumors and tumor-like lesions of the gall bladder\u2014a review","volume":"68","author":"Husain","year":"2025","journal-title":"Indian. J. Pathol. Microbiol."},{"key":"10.1016\/j.prp.2026.156705_bib20","first-page":"1","article-title":"Modulation of mitochondrial DNA copy number: therapeutic potential of phytochemicals and plant extracts\u2014a comprehensive review: MR Perrri et al","author":"Perri","year":"2026","journal-title":"Arch. Pharmacal Res."},{"key":"10.1016\/j.prp.2026.156705_bib21","series-title":"InInsights and Innovations in Gallbladder Carcinogenesis","first-page":"146","article-title":"Gallbladder Carcinogenesis: Current Insights and Future Directions","author":"Yadav","year":"2026"},{"key":"10.1016\/j.prp.2026.156705_bib22","article-title":"Genomic and molecular landscape of gallbladder cancer elucidating pathogenic mechanisms novel therapeutic targets and clinical implications","volume":"830","author":"Kumar","year":"2025","journal-title":"Mutat. Res. -Fundam. Mol. Mech. Mutagen."},{"issue":"1","key":"10.1016\/j.prp.2026.156705_bib23","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41698-022-00327-y","article-title":"Comprehensive clinicopathological and genomic profiling of gallbladder cancer reveals actionable targets in half of patients","volume":"6","author":"de Bitter","year":"2022","journal-title":"NPJ Precis. Oncol."},{"key":"10.1016\/j.prp.2026.156705_bib24","article-title":"Genomic profiling of indian gallbladder carcinoma: mutational insights in a high-incidence population","volume":"11","author":"Suryavanshi","year":"2025","journal-title":"JCO Glob. Oncol."},{"issue":"5","key":"10.1016\/j.prp.2026.156705_bib25","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.3390\/cancers14051249","article-title":"Evolving paradigms in the systemic treatment of advanced gallbladder cancer: updates in year 2022","volume":"14","author":"Hu","year":"2022","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.prp.2026.156705_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-77939-6","article-title":"Genomic profiling reveals high frequency of DNA repair genetic aberrations in gallbladder cancer","volume":"10","author":"Abdel-Wahab","year":"2020","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.prp.2026.156705_bib27","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s43152-025-00062-z","article-title":"Signaling pathways and molecular biomarkers in gallbladder cancer: a state-of-the-art review","volume":"6","author":"Saha","year":"2025","journal-title":"Curr. Tissue Microenviron. Rep."},{"key":"10.1016\/j.prp.2026.156705_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2025.104830","article-title":"Global perspective on the genetic, epigenetic, and transcriptomic basis of gallbladder cancer","volume":"214","author":"Das","year":"2025","journal-title":"Crit. Rev. Oncol. \/Hematol."},{"issue":"1","key":"10.1016\/j.prp.2026.156705_bib29","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s12029-025-01335-4","article-title":"The landscape of genomic alterations in receptor tyrosine kinase pathways in biliary cancers: implications for targeted therapies","volume":"56","author":"Voutsadakis","year":"2025","journal-title":"J. Gastrointest. Cancer"},{"key":"10.1016\/j.prp.2026.156705_bib30","first-page":"1","article-title":"Molecular profiling and targeted therapies in biliary tract cancer\u2014a short review","author":"Lentner","year":"2025","journal-title":"Memo. -Mag. Eur. Med. Oncol."},{"issue":"7","key":"10.1016\/j.prp.2026.156705_bib31","first-page":"4426","article-title":"The role of PI3K\/AKT signaling pathway in gallbladder carcinoma","volume":"14","author":"Wu","year":"2022","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.prp.2026.156705_bib32","article-title":"The potential role of miRNAs in the pathogenesis of gallbladder cancer\u2013a focus on signaling pathways interplay","volume":"248","author":"Doghish","year":"2023","journal-title":"Pathol. -Res. Pract."},{"issue":"4","key":"10.1016\/j.prp.2026.156705_bib33","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.21037\/jgo-22-61","article-title":"Clinicopathological prognostic factors for gallbladder carcinoma: a retrospective study","volume":"13","author":"Ramalhosa","year":"2022","journal-title":"J. Gastrointest. Oncol."},{"issue":"10","key":"10.1016\/j.prp.2026.156705_bib34","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00432-024-05975-0","article-title":"Research progress on prognostic factors of gallbladder carcinoma","volume":"150","author":"Miao","year":"2024","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2026.156705_bib35","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s12672-025-02886-5","article-title":"Exploration of the current status and trends of pancreatic cancer immune cells in the past 30 years: a bibliometric analysis","volume":"16","author":"Hu","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.prp.2026.156705_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2023.156271","article-title":"The present roles and future perspectives of Interleukin-6 in biliary tract cancer","volume":"169","author":"Zhou","year":"2023","journal-title":"Cytokine"},{"key":"10.1016\/j.prp.2026.156705_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1651769","article-title":"Immunotherapy in biliary tract cancer: reshaping the tumour microenvironment and advancing precision combination strategies","volume":"16","author":"Xue","year":"2025","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.prp.2026.156705_bib38","article-title":"Newer biomarkers in gallbladder carcinoma: a scoping review","volume":"16","author":"Upadhyay","year":"2024","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.prp.2026.156705_bib39","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s12029-026-01411-3","article-title":"Emergence of liquid biopsy in precision oncology: a review of its diagnostic, predictive and therapeutic applications in gallbladder cancer","volume":"57","author":"Das","year":"2026","journal-title":"J. Gastrointest. Cancer"},{"issue":"9","key":"10.1016\/j.prp.2026.156705_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.104816","article-title":"Exosomal MicroRNA signature acts as an efficient biomarker for non-invasive diagnosis of gallbladder carcinoma","volume":"25","author":"Yang","year":"2022","journal-title":"Iscience"},{"key":"10.1016\/j.prp.2026.156705_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlb.2024.100280","article-title":"Liquid biopsy in gallbladder carcinoma: current evidence and future prospective","volume":"6","author":"Mishra","year":"2024","journal-title":"J. Liq. Biopsy"},{"key":"10.1016\/j.prp.2026.156705_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.cca.2026.121016","article-title":"WH. Electrochemical microRNA biosensors for gallbladder cancer: translational perspectives for clinical chemistry and point-of-care diagnostics","author":"Goyal","year":"2026","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.prp.2026.156705_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1027914","article-title":"Proteomic profiling of cell line-derived extracellular vesicles to identify candidate circulatory markers for detection of gallbladder cancer","volume":"12","author":"Priya","year":"2022","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2026.156705_bib44","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s42047-025-00188-2","article-title":"Biogenesis, function and role of circular RNA in gall bladder carcinoma-a narrative review","volume":"8","author":"Singh","year":"2025","journal-title":"Surg. Exp. Pathol."},{"issue":"3","key":"10.1016\/j.prp.2026.156705_bib45","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1080\/00325481.2024.2345585","article-title":"Gallbladder cancer: surgical treatment, immunotherapy, and targeted therapy","volume":"136","author":"Sun","year":"2024","journal-title":"Postgrad. Med."},{"issue":"2","key":"10.1016\/j.prp.2026.156705_bib46","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s13193-022-01654-z","article-title":"A systemic review and meta-analysis of laparoscopic surgery versus open surgery for gallbladder cancer","volume":"15","author":"Karjol","year":"2024","journal-title":"Indian J. Surg. Oncol."},{"key":"10.1016\/j.prp.2026.156705_bib47","first-page":"1","article-title":"Perioperative approaches for patients with biliary tract cancer","author":"Zorigtbaatar","year":"2026","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.prp.2026.156705_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2026.1750154","article-title":"Treatment of biliary tract cancer-essentials for clinical practice","volume":"16","author":"Liberko","year":"2026","journal-title":"Front. Oncol."},{"issue":"23","key":"10.1016\/j.prp.2026.156705_bib49","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70196","article-title":"Chemoradiation of locally advanced biliary cancer: a PRISMA-compliant systematic review","volume":"13","author":"Bisello","year":"2024","journal-title":"Cancer Med."},{"key":"10.1016\/j.prp.2026.156705_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2026.105152","article-title":"Multifaceted mechanisms and precision strategies to overcome therapeutic resistance in gallbladder cancer","author":"Jiang","year":"2026","journal-title":"Crit. Rev. Oncol. \/Hematol."},{"issue":"6","key":"10.1016\/j.prp.2026.156705_bib51","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.3390\/cancers14061413","article-title":"Treatment of resectable gallbladder cancer","volume":"14","author":"Vega","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2026.156705_bib52","first-page":"1","article-title":"Perioperative chemotherapy for clinical stage IIIB gallbladder cancer: a review of the National Cancer Database","volume":"0","author":"Wylie","year":"2026","journal-title":"Int. J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.prp.2026.156705_bib53","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1080\/17474124.2021.1853527","article-title":"Recent advances of immunotherapy for biliary tract cancer","volume":"15","author":"Rizzo","year":"2021","journal-title":"Expert. Rev. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.prp.2026.156705_bib54","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41575-022-00741-4","article-title":"Immunology and immunotherapy of cholangiocarcinoma","volume":"20","author":"Greten","year":"2023","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.prp.2026.156705_bib55","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12967-022-03231-y","article-title":"Evaluation of exosomal non-coding RNAs in cancer using high-throughput sequencing","volume":"20","author":"Hosseini","year":"2022","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.prp.2026.156705_bib56","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.985089","article-title":"Bile-derived exosome noncoding RNAs as potential diagnostic and prognostic biomarkers for cholangiocarcinoma","volume":"12","author":"Pan","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.prp.2026.156705_bib57","first-page":"897","article-title":"Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer","volume":"386","author":"Oh","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.prp.2026.156705_bib58","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.annonc.2022.10.506","article-title":"Biliary tract cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"34","author":"Vogel","year":"2023","journal-title":"Ann. Oncol."},{"issue":"8","key":"10.1016\/j.prp.2026.156705_bib59","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.3390\/cancers15082376","article-title":"Targeting angiogenesis in the era of biliary tract cancer immunotherapy: biological rationale, clinical implications, and future research avenues","volume":"15","author":"Schirizzi","year":"2023","journal-title":"Cancers"},{"issue":"8","key":"10.1016\/j.prp.2026.156705_bib60","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S2468-1253(24)00095-5","article-title":"Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study","volume":"9","author":"Oh","year":"2024","journal-title":"Lancet Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.prp.2026.156705_bib61","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3390\/curroncol29020050","article-title":"Systemic treatment for metastatic biliary tract cancer: state of the art and a glimpse to the future","volume":"29","author":"Rizzo","year":"2022","journal-title":"Curr. Oncol."},{"issue":"01","key":"10.1016\/j.prp.2026.156705_bib62","doi-asserted-by":"crossref","first-page":"087","DOI":"10.1055\/s-0041-1735631","article-title":"Mechanisms of pharmacoresistance in hepatocellular carcinoma: new drugs but old problems","volume":"42","author":"Marin","year":"2022","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.prp.2026.156705_bib63","doi-asserted-by":"crossref","DOI":"10.1177\/17588359211036544","article-title":"IMbrave 151: a randomized phase II trial of atezolizumab combined with bevacizumab and chemotherapy in patients with advanced biliary tract cancer","volume":"13","author":"Hack","year":"2021","journal-title":"Ther. Adv. Med. Oncol."},{"issue":"10272","key":"10.1016\/j.prp.2026.156705_bib64","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0140-6736(21)00153-7","article-title":"Biliary tract cancer","volume":"397","author":"Valle","year":"2021","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.prp.2026.156705_bib65","doi-asserted-by":"crossref","first-page":"602","DOI":"10.4143\/crt.2023.726","article-title":"A single-arm phase II study of nab-paclitaxel plus gemcitabine and cisplatin for locally advanced or metastatic biliary tract cancer","volume":"56","author":"Liu","year":"2023","journal-title":"Cancer Res. Treat."},{"key":"10.1016\/j.prp.2026.156705_bib66","doi-asserted-by":"crossref","unstructured":"Jayaraman, MR, V, L, Grace Priyadarshini, S, An Unusual Case of Hepatocellular Carcinoma in a Healthy Adolescent Male., Cureus, 2024, 16, e58357.","DOI":"10.7759\/cureus.58357"},{"issue":"8","key":"10.1016\/j.prp.2026.156705_bib67","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200015","article-title":"Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer","volume":"1","author":"Oh","year":"2022","journal-title":"NEJM Evid."},{"key":"10.1016\/j.prp.2026.156705_bib68","first-page":"1","article-title":"Immune-checkpoint inhibitors for advanced hepatocellular carcinoma in Child\u2013Turcotte\u2013Pugh-B cirrhosis: a liver-centric approach to outcomes beyond tumor progression","author":"Agrawal","year":"2026","journal-title":"Hepatol. Int."},{"issue":"3","key":"10.1016\/j.prp.2026.156705_bib69","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1080\/14740338.2024.2446405","article-title":"Safety of current treatments for advanced cholangiocarcinoma","volume":"24","author":"de Castria","year":"2025","journal-title":"Expert. Opin. Drug. Saf."},{"issue":"1","key":"10.1016\/j.prp.2026.156705_bib70","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1146\/annurev-pathol-030220-020455","article-title":"Pathogenesis of cholangiocarcinoma","volume":"16","author":"Rodrigues","year":"2021","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"issue":"11","key":"10.1016\/j.prp.2026.156705_bib71","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1080\/17512433.2025.2590695","article-title":"Immunotherapy in biliary tract cancer: effective but not enough?","volume":"18","author":"Rizzo","year":"2025","journal-title":"Expert. Rev. Clin. Pharmacol."},{"issue":"11","key":"10.1016\/j.prp.2026.156705_bib72","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.3390\/cancers15113047","article-title":"Third-line palliative systemic therapy for advanced biliary tract cancer: multicentre review of patterns of care and outcomes","volume":"15","author":"Gray","year":"2023","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.prp.2026.156705_bib73","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1097\/HEP.0000000000001200","article-title":"International trends in biliary tract cancer\u2013related mortality, 2000\u20132022: an observational study of the World Health Organization Mortality Database","volume":"82","author":"Vu","year":"2025","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.prp.2026.156705_bib74","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1109\/TCBB.2020.2973148","article-title":"FUNMarker: fusion network-based method to identify prognostic and heterogeneous breast cancer biomarkers","volume":"18","author":"Li","year":"2020","journal-title":"IEEE\/ACM Trans. Comput. Biol. Bioinforma."},{"issue":"3","key":"10.1016\/j.prp.2026.156705_bib75","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000632","article-title":"Deep immune profiling of intrahepatic cholangiocarcinoma with CODEX multiplexed imaging","volume":"9","author":"Baretti","year":"2025","journal-title":"Hepatol. Commun."},{"issue":"9","key":"10.1016\/j.prp.2026.156705_bib76","doi-asserted-by":"crossref","first-page":"7781","DOI":"10.3390\/ijms24097781","article-title":"Machine learning models for the identification of prognostic and predictive cancer biomarkers: a systematic review","volume":"24","author":"Al-Tashi","year":"2023","journal-title":"Int. J. Mol. Sci."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826003584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826003584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T03:53:21Z","timestamp":1791345201000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033826003584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":76,"alternative-id":["S0344033826003584"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2026.156705","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systematic review of gallbladder disorders: Molecular pathogenesis, biomarkers, diagnostic approaches, and emerging therapeutic strategies","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2026.156705","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156705"}}